Trademark: 98402369
Word
ALBENMED
Status Date
Friday, September 20, 2024
Filing Date
Monday, February 12, 2024
5 Pharmaceutical compositions and medicaments for use in treatment of cancer; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, inhibiting the proliferation, metastasis and angiogenic activity of malignant cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, regulation of one or more kinase signaling pathway, reversing multi-drug resistance, inhibiting tumor stem cells; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, providing anti-inflammatory and antiviral properties; Pharmaceutical compositions and medicaments for use in the treatment of cancer
The mark was first used anywhere in a different form other than that sought to be registered at least as early as
ALBEN MED
The mark was first used anywhere in a different form other than that sought to be registered at least as early as
Feb 12, 2024
New Application Entered
Jun 12, 2024
New Application Office Supplied Data Entered
Sep 5, 2024
Assigned To Examiner
Sep 10, 2024
Non-Final Action E-Mailed
Sep 10, 2024
Non-Final Action Written
Sep 10, 2024
Notification Of Non-Final Action E-Mailed
Sep 20, 2024
Teas/Email Correspondence Entered
Sep 20, 2024
Teas/Email Correspondence Entered
Sep 20, 2024
Correspondence Received In Law Office
Sep 20, 2024
Correspondence Received In Law Office
Sep 20, 2024
Teas Response To Office Action Received
Sep 20, 2024
Teas Response To Office Action Received
Trademark Alertz updated from USPTO on 2030-01-24
